register free | resend password

Pressemitteilungen zu dem Thema regenerative medicine


Unterkategorien

PresseMitteilungen zu dem Schlagwort regenerative medicine


The Alliance for Regenerative Medicine Releases Agenda for Fifth Annual 2017 European Advanced Therapies Investor Day

LONDON, UNITED KINGDOM and WASHINGTON, DC -- (Marketwired) -- 10/17/17 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader regenerative medicine sector, along with co-hosts UK BioIndustry Association (BIA) and the Cell and Gene Therapy Catapult, releases the agenda for its annual European Advanced Therapies Investor Day, to be held November 9, 2017 in London.Now in its fifth year, this one-day, invitation-on ...


17.10.2017

The Alliance for Regenerative Medicine Announces Election of 2018 ARM Executive Committee and Board of Directors

WASHINGTON, DC -- (Marketwired) -- 10/04/17 -- The Alliance for Regenerative Medicine (ARM), announced today the election of its 2018 Executive Committee and Board of Directors.The Executive Committee and Board of Directors oversee the formation and execution of ARM''s strategic priorities and focus areas over the coming year. Each group is held to an annual re-election or rotation process, with nominations and approval by the ARM membership and current Board."We are excited to w ...


04.10.2017

The Alliance for Regenerative Medicine Submits Letter to Congress Detailing Concerns with the Senate''s American Health Care Act

WASHINGTON, DC -- (Marketwired) -- 09/22/17 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cellular therapies and broader regenerative medicine sector, today sent a letter to U.S. Sens. Graham (R-SC), Cassidy, MD (R-LA), Heller (R-NV) and Johnson (R-WI), detailing concerns regarding the American Health Care Act (H.R. 1628).The letter, signed by ARM CEO Janet Lambert, addresses the organization''s primary concern that ...


22.09.2017

Asana Medical, Inc. to Present as Innovation Challenge Finalist at RESI Boston Conference 2017

MIAMI LAKES, FL -- (Marketwired) -- 09/11/17 -- ., ("Asana," the "Company"), a regenerative medicine company developing a novel treatment for Ulcerative Colitis, is pleased to announce that it has been selected as an Innovation Challenge Finalist and will present at the in Boston, Massachusetts on Tuesday, September 26th, 2017. The RESI (Redefining Early Stage Investments) Conference is an investor conference for early-stage life science companies, and is being held at the ...


11.09.2017

Dr. Susan G. Manella Joins Asana''s Medical Advisory Board

MIAMI LAKES, FL -- (Marketwired) -- 08/24/17 -- ., ("Asana," the "Company"), a regenerative medicine company that is developing a novel treatment for Inflammatory Bowel Disease ("IBD"), including Ulcerative Colitis and Crohn''s Disease, is pleased to announce that Dr. Susan G. Manella has accepted the Company''s offer to join its Medical Advisory Board. Dr. Manella will assume the board''s leadership role in managing information flow a ...


24.08.2017

The Alliance for Regenerative Medicine Releases Q2 2017 Data Report, Highlighting Sector Trends and Metrics

WASHINGTON, DC -- (Marketwired) -- 08/18/17 -- The Alliance for Regenerative Medicine (ARM) released today its most recent quarterly data report, offering an in-depth look at cell therapy, gene therapy, tissue engineering and broader global regenerative medicine sector trends and metrics in the second quarter and first half of 2017.Using information provided by ARM''s data partner Informa, the quarterly data report details industry-specific statistics compiled from more than 822 cell ...


18.08.2017

The Alliance for Regenerative Medicine Issues Statement in Response to Reports of the First Use of Gene Editing Technology in Human Embryos in the U.S.

WASHINGTON, DC -- (Marketwired) -- 07/27/17 -- The Alliance for Regenerative Medicine (ARM) has issued the following statement in response to the news that a research team from the Oregon Health and Science University has, for the first time in the United States, utilized gene editing technology to modify human embryos:ARM continues to monitor the latest developments in gene-editing technologies, given their enormous medical potential. We reiterate our encouragement and support of the use of th ...


27.07.2017

The Alliance for Regenerative Medicine Announces Second Reimbursement and Market Access-Focused White Paper in Three-Part Series Published in In Vivo

WASHINGTON, DC -- (Marketwired) -- 07/24/17 -- The Alliance for Regenerative Medicine (ARM) today announced the publication of its reimbursement and market-access focused white paper, "New Payment and Financing Models for Curative Regenerative Medicines," available today in In Vivo.Authored by Ted Slocomb of Audentes Therapeutics; Ted Haack of LatticePoint Consulting; Satish Valluri of Pfizer; Beth Rader of BioMarin; and Michael Werner of ARM, this white paper, the second in ARM' ...


24.07.2017

The Alliance for Regenerative Medicine Announces Presenting Companies at 2017 Cell & Gene Meeting on the Mesa

WASHINGTON, DC -- (Marketwired) -- 07/19/17 -- The Alliance for Regenerative Medicine (ARM) today announced the initial slate of companies selected to present at its upcoming Cell & Gene Meeting on the Mesa annual conference, October 4-6, 2017.Over the course of the three-day conference, more than 850 are expected to attend, including executives from leading companies, venture capital and institutional investors, tools and development platform providers, clinicians, patients and patient adv ...


19.07.2017

PolarityTE(TM) Expands Clinical Board of Advisors with Focus on World-Renowned Burn and Wound Care Specialists

SALT LAKE CITY, UT -- (Marketwired) -- 06/30/17 -- PolarityTE™, Inc. (NASDAQ: COOL) today announced the appointment of some of the world''s most-highly-regarded experts in burn and wound care to its Clinical Board of Advisors, as it drives toward the introduction of the Company''s flagship product, SkinTE™. This cadre of plastic and reconstructive surgeons includes Drs. Martin C. Robson, William L. Hickerson, Jeffrey W. Shupp, Mark S. Granick, David J. Smith, Jr. and Gerhard ...


30.06.2017

The Alliance for Regenerative Medicine Announces the Appointment of Janet Lynch Lambert as Chief Executive Officer

WASHINGTON, DC -- (Marketwired) -- 06/27/17 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cellular therapies and broader regenerative medicine sector, formally announces that its Board of Directors has named Janet Lynch Lambert as the organization''s first chief executive officer. The organization informed its membership early last week of the decision."We are delighted to add Janet to the ARM team at this very ...


27.06.2017

PolarityTE(TM) Appoints Distinguished Major General Jay Hood of the U.S. Army as Director of Newly Created Military and Mass Casualty Advisory Board

SALT LAKE CITY, UT -- (Marketwired) -- 06/27/17 -- PolarityTE™, Inc. (NASDAQ: COOL) today announced the appointment of Major General (U.S. Army - Retired) Jay Hood as the Director of the Company''s newly formed Military and Mass Casualty Advisory Board. Major General Hood amassed more than 36 years of service to the United States as an Army Officer."I am proud to announce the formation of the PolarityTE™ Military and Mass Casualty Advisory Board with the appointment of Major Gene ...


27.06.2017

PolarityTE(TM) Appoints Clinical Expert and Industry Insider Dr. Wayne Saunders to the Clinical Board of Advisors

SALT LAKE CITY, UT -- (Marketwired) -- 06/21/17 -- PolarityTE™, Inc. (NASDAQ: COOL) today announced the appointment of Wayne J. Saunders, DMD to the Company''s Clinical Board of Advisors. Dr. Saunders is Chief of Oral and Maxillofacial Surgery and Dentistry at St. Luke''s University Hospital in Bethlehem, PA, and is widely-regarded as an expert in dental implants and maxillofacial trauma."As we develop the PolarityTE™ technology platform, we continue to leverage the exp ...


21.06.2017

BioStem Technologies, Inc. Announces Letter of Intent with Watermakers, Inc. to begin testing on Staniel Cay in the Exuma Cays, Bahamas

POMPANO BEACH, FL -- (Marketwired) -- 06/09/17 -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BSEM" or "the company"), a global corporation providing world-class solutions focused on Regenerative Medicines, Pharmaceuticals and Blue Technologies, is eager to announce that its Oakland Park, Florida based subsidiary, BioBlue Technologies Inc. ("BioBlue"), has signed a Letter of Intent ("LOI") with Watermakers, Inc. for industrial water treatment.Staniel Ca ...


09.06.2017

PolarityTE(TM) Regenerates Full-Thickness Hair-Bearing Skin in Burns and Wounds Using Their Revolutionary Platform Technology

SALT LAKE CITY, UT -- (Marketwired) -- 06/08/17 -- PolarityTE™, Inc. (NASDAQ: COOL) today announced pre-clinical results demonstrating that the Company''s lead product, SkinTE™, regenerated full-thickness, organized skin and hair follicles in third degree burn wounds. The findings represent the first known successful regeneration of skin and hair in full-thickness swine wound models, the standard animal model for human skin. The Company expects to initiate a human clinical trial evalu ...


08.06.2017

The Alliance for Regenerative Medicine Announces Speakers and "Legislator of the Year" Award Recipients for Eighth Annual Dinner and Legislative Fly-In

WASHINGTON, DC -- (Marketwired) -- 05/11/17 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cellular therapies and broader regenerative medicine sector, announced the speaker line up for its eighth Annual Dinner and Legislative Fly-In, to be held May 23 and 24 in Washington, D.C. This event honors recent accomplishments in the sector and enables ARM members to advocate on Capitol Hill for legislative support of gene and cellular ...


11.05.2017

The Alliance for Regenerative Medicine Releases Agenda for Inaugural Cell & Gene Exchange

WASHINGTON, DC -- (Marketwired) -- 05/09/17 -- The Alliance for Regenerative Medicine (ARM) today released the agenda for the inaugural Cell & Gene Exchange, the only partnering conference that brings together the regulatory, business and patient advocacy communities across the cell and gene therapy sectors. Co-produced by ARM and EBD Group and held in partnership with Global Genes, the event will take place May 22 and 23 in Washington, D.C."Our industry is on the cusp of some truly re ...


09.05.2017

PolarityTE(TM), Inc. Enters Formal Agreement with Cell Therapy and Regenerative Medicine, A Leading Cell Therapy Manufacturer in the Intermountain West

SALT LAKE CITY, UT -- (Marketwired) -- 04/20/17 -- PolarityTE™, Inc. ("Polarity") (NASDAQ: COOL) announces the signing of a manufacturing agreement with Cell Therapy and Regenerative Medicine ("CTRM") at the University of Utah School of Medicine. CTRM is the established manufacturer of hematopoietic stem cell transplants for renowned institutions of the Salt Lake region such as the Huntsman Cancer Institute and Primary Children''s Hospital. In addition, CTRM manufa ...


20.04.2017

PolarityTE(TM), Inc. Recruits Key Additions to Management

SALT LAKE CITY, UT -- (Marketwired) -- 04/18/17 -- PolarityTE™, Inc. ("Polarity") (NASDAQ: COOL) announces the recruitment of six new members to its growing team with specific expertise and experience in government and defense contracts, intellectual property and FDA legal strategy, and translational research and development.Chairman and Chief Executive Officer, Denver M. Lough, MD, PhD stated, "With such recent and significant growth, Polarity is proud to announce that we have r ...


18.04.2017

Pharmaceutical Industry Executive Brian W. Andersen Named Chief Business Officer at Asana Medical, Inc.

MIAMI LAKES, FL -- (Marketwired) -- 04/18/17 -- ., ("Asana," the "Company"), a regenerative medicine company that is developing a novel treatment for Inflammatory Bowel Disease ("IBD"), including Ulcerative Colitis and Crohn''s Disease, is pleased to announce that Brian W. Andersen, an experienced industry executive with a proven record of commercial excellence, has been appointed as its Chief Business Officer.Mr. Andersen brings to Asana an impressive tr ...


18.04.2017

PolarityTE(TM) Inc. Announces Completion of Merger and Acquires Important Intellectual Property for Regenerative Medicine Programs

SALT LAKE CITY, UT -- (Marketwired) -- 04/07/17 -- PolarityTE™, Inc., (NASDAQ: COOL) today announced the completion of a previously announced merger. The Company will continue to trade under the NASDAQ symbol COOL.Denver Lough, Chairman and Chief Executive Officer of Polarity, stated, "We are thrilled and excited to announce the completion of this merger, which we believe dramatically propels the future development of PolarityTE™. Numerous parties have dedicated tremendous amounts of work ...


07.04.2017

The Alliance for Regenerative Medicine Releases Agenda for Fifth Annual Cell & Gene Therapy Investor Day

WASHINGTON, DC -- (Marketwired) -- 04/06/17 -- The Alliance for Regenerative Medicine (ARM) today released the complete agenda for its upcoming fifth annual Cell & Gene Therapy Investor Day, taking place April 27, 2017 in Boston, MA. This event, co-hosted by Piper Jaffray and held in partnership with Cowen and Company is the only investor conference specifically focused on cell and gene therapies, offering exclusive access to the field''s most promising companies.This year'&# ...


06.04.2017

Global Burn Surgery Expert Dr. Stephen Milner is Recruited from Role as Director of The Johns Hopkins Burn Center and is Appointed as Chief Clinical Officer of PolarityTE(TM), Inc.

SOUTH PLAINFIELD, NJ -- (Marketwired) -- 03/27/17 -- PolarityTE™, Inc. ("Polarity") (NASDAQ: COOL) announces that Dr. Stephen Milner (drstephenmilner.org) will join the company in a full-time capacity as Chief Clinical Officer following his resignation from Johns Hopkins as Professor of Plastic and Reconstructive Surgery and Pediatrics and Director of the Burn Center on March 30, 2017.As Chief Clinical Officer, Dr. Milner will utilize his extensive network of burn and wound care surge ...


27.03.2017

Alliance for Regenerative Medicine Comments on Nomination of Scott Gottlieb as FDA Commissioner

WASHINGTON, DC -- (Marketwired) -- 03/13/17 -- The Alliance for Regenerative Medicine (ARM) today issued the following statements on the Trump Administration''s nomination of Scott Gottlieb, M.D., as commissioner of the U.S. Food and Drug Administration (FDA).ARM Chairman Robert Preti, Ph.D. said, "As a former practicing physician, FDA deputy commissioner and senior policy advisor for the Centers for Medicaid and Medicare Services, Dr. Gottlieb is a great choice to oversee the FD ...


13.03.2017

PolarityTE(TM) Inc. Stockholders Approve Merger

SOUTH PLAINFIELD, NJ -- (Marketwired) -- 03/13/17 -- PolarityTE™, Inc., ("Polarity") (NASDAQ: COOL) today announced the voting results from it special meeting (the "Meeting") held on March 10, 2017.A total of 3,369,498 shares of common stock, including shares of common stock underlying shares of outstanding preferred stock were represented at the Meeting. The shareholders voted on and approved all matters brought before the Meeting and obtained over 99% votes in favor to con ...


13.03.2017

PolarityTE(TM) Inc. Appoints Business Strategy and Innovation Expert Jeff Dyer, MBA, PhD to Board of Directors

SOUTH PLAINFIELD, NJ -- (Marketwired) -- 03/08/17 -- , (NASDAQ: COOL) today announced it has appointed Jeff Dyer, MBA, PhD, expert in business strategy and innovation to its Board of Directors."As we bring the vision of PolarityTE™ to fruition, we are excited to announce the appointment of a world class business strategist and scholar in innovation like Jeff Dyer to our Board of Directors. His career both working in the formative years of Bain & Company and studying the most innovative ...


08.03.2017

The Alliance for Regenerative Medicine Releases 2016 Annual Data Report, Highlighting Sector Trends and Metrics

WASHINGTON, DC -- (Marketwired) -- 03/07/17 -- The Alliance for Regenerative Medicine (ARM) today announced the release of its 2016 annual data report, offering an in-depth look at trends and metrics for the cell therapy, gene therapy, tissue engineering and broader global regenerative medicine sector.Using data provided by ARM''s data partner Informa and compiled and analyzed by ARM''s staff, the report details industry-specific statistics and trends from more than 730 lead ...


07.03.2017

PolarityTE(TM) Inc. Appoints Artificial Intelligence and Cognitive Computing Leader Burke Powers as VP of Product Development

SOUTH PLAINFIELD, NJ -- (Marketwired) -- 02/28/17 -- , (NASDAQ: COOL) today announced it has appointed Burke Powers as Vice President of Product Development. Mr. Powers has extensive experience building and commercializing products both in healthcare and other sectors utilizing artificial intelligence and big data anlytics."The addition of Burke Powers to PolarityTE marks yet another major milestone as we assemble the pieces to fulfill our vision to approach tissue engineering from a new p ...


28.02.2017

PolarityTE(TM) Inc. Regains Compliance With NASDAQ Independent Director Requirement

SOUTH PLAINFIELD, NJ -- (Marketwired) -- 02/22/17 -- , (NASDAQ: COOL) today announced it has received formal notification from the Listing Qualifications Department of The NASDAQ Stock Market ("NASDAQ") notifying PolarityTE™ that it has regained compliance with Listing Rule 5605(b)(1), the independent director requirement for continued listing on The NASDAQ Stock Market, with the appointment of Mr. Steve Gorlin and Dr. Jon Mogford, and that the matter is now closed. PolarityTE™'& ...


22.02.2017

The Alliance for Regenerative Medicine Publishes Position on Hospital Exemption of Advanced Therapy Medicinal Products in Europe

BRUSSELS, BELGIUM and WASHINGTON, DC -- (Marketwired) -- 02/16/17 -- The (ARM), the international advocacy organization representing the cell and gene therapy and broader regenerative medicine and advanced therapies sector, today announced it has published its position on Hospital Exemption (HE) in response to vastly different interpretations and implementations across the European Union of Article 3(7) of Directive 2001/83/EC within article 28 (2) of the Advanced Therapy Medicinal Products (A ...


16.02.2017

PolarityTE(TM) Inc. Appoints Jon Mogford, PhD to the Board of Directors

SOUTH PLAINFIELD, NJ -- (Marketwired) -- 02/16/17 -- , (NASDAQ: COOL) today announced it has appointed Jon Mogford, PhD to the Board of Directors. Dr. Mogford has extensive experience in regenerative medicine and wound healing, with a long track record of leading large research institutions. He currently oversees research strategy as Vice Chancellor for Research across the entire Texas A&M University System, and led significant expansion and collaborations while serving as Deputy Director o ...


16.02.2017

The Alliance for Regenerative Medicine Releases Statement in Response to National Academies Report on Human Genome Editing

WASHINGTON, DC -- (Marketwired) -- 02/14/17 -- The National Academies of Sciences, Engineering and Medicine today issued a report that examines the scientific, clinical, ethical, legal and social implications of human genome editing. The Alliance for Regenerative Medicine (ARM) believes that genomic medicines, including genome editing, hold great promise for the treatment of a multitude of hereditary and acquired diseases where there is presently no effective treatment available.ARM issued the ...


14.02.2017

PolarityTE(TM) Inc. Appoints Regenerative Medicine Pioneer Steve Gorlin to the Board of Directors

SOUTH PLAINFIELD, NJ -- (Marketwired) -- 02/09/17 -- (NASDAQ: COOL) today announced it has appointed Steve Gorlin to the Board of Directors. Mr. Gorlin has extensive experience building successful biotechnology companies, and is a leader in regenerative medicine, pharmaceutical drug and medical device research and development."We are extremely excited to announce Steve Gorlin as a new member of the PolarityTE™ Board of Directors. With over 40 successful years in the field, he remains a le ...


09.02.2017

The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Fifth Annual Cell & Gene Therapy Investor Day

WASHINGTON, DC -- (Marketwired) -- 02/02/17 -- The Alliance for Regenerative Medicine (ARM) today announced its annual Cell & Gene Therapy Investor Day will take place April 27, 2017 in Boston, MA. The event is co-hosted by leading investment firm Piper Jaffray and held in partnership with Cowen & Co."Cell and gene therapies, including gene editing technologies and tissue engineering, are providing significant investment opportunities for institutional, venture, corporate strategic ...


02.02.2017

The Alliance for Regenerative Medicine to Host "21st Century Cures for Cell & Gene Therapies" Webinar on February 2, 2017

WASHINGTON, DC -- (Marketwired) -- 01/30/17 -- The (ARM) today announced it will host a free webinar titled "Understanding the 21st Century Cures Act for Cell & Gene Therapies." During this one-hour live event, Michael Werner, Executive Director for ARM will be joined by Director Wilson W. Bryan, M.D., and Deputy Director Rachael F. Anatol, Ph.D., of the U.S. Food and Drug Administration''s (FDA) Center for Biologics Evaluation and Research (CBER) Office of Tissues and ...


30.01.2017

The Alliance for Regenerative Medicine Launches Standards Coordinating Body to Advance Development and Establishment of Industry-Wide Standards

WASHINGTON, DC -- (Marketwired) -- 01/19/17 -- The (ARM) today announced the formal launch of the international for regenerative medicines (SCB), a public-private partnership for coordinating, prioritizing and supporting standards that advances process, measurement and analytical techniques to support the global availability of products across the gene and gene-modified cell therapy, cell therapy, cell-based drug discovery, tissue engineering and biomaterials sectors."Development of ind ...


19.01.2017

Majesco Entertainment Company Reports Name Change to PolarityTE(TM), Inc.

SOUTH PLAINFIELD, NJ -- (Marketwired) -- 01/10/17 -- (NASDAQ: COOL) following its previous announcement that it signed a definitive merger agreement with a Nevada corporation , (the "Merger") today announced that the Company''s name has been changed to PolarityTE™, Inc., effective with The NASDAQ Capital Market at the open of business on January 11, 2017. The Company''s new CUSIP will be 731094108 and its common stock will continue to trade under the symbol &quo ...


10.01.2017

PolarityTE(TM) Inc. Adds Prominent Surgical Leaders to the Clinical Advisory Board

SOUTH PLAINFIELD, NJ -- (Marketwired) -- 01/09/17 -- (NASDAQ: COOL) following announcement that it had signed a definitive merger agreement with , (the "Merger") supplements its esteemed Clinical Board of Advisors with more innovative thought leaders in plastic and reconstructive surgery and regenerative medicine with Drs. Bentz, Bluebond-Langner, and Katz. Denver Lough MD, PhD, Chairman and CEO, remarked, "PolarityTE is focused on delivering transformative tissue engineering p ...


09.01.2017

The Alliance for Regenerative Medicine Announces 2017 Cell & Gene Therapies State of the Industry Briefing

WASHINGTON, DC -- (Marketwired) -- 12/15/16 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapies and broader regenerative medicine sector, announced its 2017 Cell & Gene Therapies State of the Industry briefing will take place January 9, 2017 in San Francisco, held in conjunction with Biotech Showcase™ 2017.ARM''s State of the Industry briefing is the largest cell and gene therapy-focused annual event tak ...


15.12.2016

PolarityTE(TM) Inc., names World Renowned Plastic & Reconstructive Surgeon Michael W. Neumeister, MD, FRCSC, FACS, as Chief Medical Officer

SOUTH PLAINFIELD, NJ -- (Marketwired) -- 12/09/16 -- (NASDAQ: COOL) following announcement that it had signed a definitive merger agreement with announced it has appointed Michael W. Neumeister, MD, FRCSC, FACS as Chief Medical Officer (). Dr. Neumeister was formerly President of the Plastic Surgery Foundation and Plastic Surgery Research Council and is a Leader in Regenerative Medicine (). Following satisfaction of the conditions to closing, including approval of stockholders, Polarity will ...


09.12.2016

Majesco Entertainment Inc. and PolarityTE, Inc. Enter Into Merger Agreement

SOUTH PLAINFIELD, NJ -- (Marketwired) -- 12/08/16 -- Majesco Entertainment, Inc. (NASDAQ: COOL) ("Majesco"), announced today it had signed a definitive merger agreement with PolarityTE, Inc. ("Polarity") . Polarity is an entirely new and radically unique regenerative medicine company committed to developing the first forms of functionally-polarized autologous tissues for use in medical procedures requiring reconstructive applications by surgeons and wound care specialists.Up ...


08.12.2016

The Alliance for Regenerative Medicine Commends Passage of 21st Century Cures Act, Inclusion of Regenerative Medicine-Specific Provisions

WASHINGTON, DC -- (Marketwired) -- 12/01/16 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cellular therapies and broader regenerative medicine sector, commends the U.S. House of Representatives'' bipartisan passage of the 21st Century Cures Act.ARM is particularly pleased the bill includes regenerative medicine-specific provisions intended to optimize the U.S. Food and Drug Administration''s (FDA) approval ...


01.12.2016

The Alliance for Regenerative Medicine Announces Inherited Blood Disorders Clinical and Patient Education Roundtable

WASHINGTON, DC -- (Marketwired) -- 11/17/16 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cellular therapies and broader regenerative medicine sector, announced it will hold its Inherited Blood Disorders Clinical and Patient Education Roundtable December 13 in Washington, D.C., the third event in its patient roundtable series.ARM''s patient roundtable series is intended to serve as an educational resource for the bro ...


17.11.2016

Alliance for Regenerative Medicine Launches Reimbursement and Market Access-Focused White Paper Series, First Paper Published in In Vivo

WASHINGTON, DC -- (Marketwired) -- 11/15/16 -- The Alliance for Regenerative Medicine (ARM) today announced the launch of its three-part white paper series focused on the value and adoption of future gene and cell therapies. The first paper, "" is available online today in In Vivo, a publication focusing on the global medical and healthcare industry.The white paper series is part of a broader initiative of ARM''s Reimbursement Committee, intended to explore current and futur ...


15.11.2016

Alliance for Regenerative Medicine Releases Q3 2016 Data Report, Highlighting Sector Trends and Metrics

WASHINGTON, DC -- (Marketwired) -- 11/10/16 -- The Alliance for Regenerative Medicine (ARM) today announced the release of its quarterly data report, offering an in-depth look at cell therapy, gene therapy, tissue engineering and broader global regenerative medicine sector trends and metrics in the third quarter of 2016.Using information provided by ARM''s data partner Informa, the quarterly data report details industry-specific statistics compiled from more than 730 cell therapy, gen ...


10.11.2016

The Alliance for Regenerative Medicine Announces Election of 2017 ARM Officers, Executive Committee and Board of Directors

WASHINGTON, DC -- (Marketwired) -- 10/11/16 -- The Alliance for Regenerative Medicine (ARM), announced today the election of the 2017 ARM Officers, Executive Committee and Board of Directors."ARM leadership reflects the geographical and technological diversity of our membership," said Morrie Ruffin, managing director of ARM. "We welcome these new slates of officers, directors and executive committee members; each has demonstrated direct involvement and active participation in ARM ...


11.10.2016

The Alliance for Regenerative Medicine Announces Fourth Annual 2016 European Advanced Therapies Investor Day

WASHINGTON, DC -- (Marketwired) -- 09/28/16 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader regenerative medicine sector, announced its annual European Advanced Therapies Investor Day will be held November 3, 2016 in London.Now in its fourth year, this conference is the only European-centric investor meeting focused exclusively on the advanced therapy sector. This one-day program provides institutional, ...


28.09.2016

The Alliance for Regenerative Medicine Submits Comments in Response to the European Commission''s Draft Guidelines on Good Manufacturing Practice for Advanced Therapy Medicine Products

BRUSSELS, BELGIUM and WASHINGTON, DC -- (Marketwired) -- 09/27/16 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader regenerative medicine sector, has submitted written comments in response to the European Commission (EC)-issued targeted stakeholder consultation document on the draft Guidelines on Good Manufacturing Practice for Advanced Therapy Medicine Products (ATMP).The consultation document is of criti ...


27.09.2016

Standards Coordinating Body for Regenerative Medicines and the National Institute of Standards and Technology Enter Into a Memorandum of Understanding to Advance Development and Establishment of Industry-Wide Standards

WASHINGTON, DC -- (Marketwired) -- 09/19/16 -- The Alliance for Regenerative Medicine: The Standards Coordinating Body for Gene, Cell and Regenerative Medicines and Cell-based Drug Discovery (SCB) announced today it has entered into a memorandum of understanding (MOU) with the National Institute of Standards and Technology''s (NIST) Material Measurement Laboratory (MML) to advance the development of industry-wide standards for cell therapy, gene therapy, regenerative medicine and cell ...


19.09.2016

The Alliance for Regenerative Medicine Submits Comments in Response to FDA Draft Guidances on the Regulation of Human Cells, Tissues or Cellular or Tissue-Based Products

WASHINGTON, DC -- (Marketwired) -- 09/12/16 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader regenerative medicine sector, submitted written comments today in response to the FDA-issued draft guidances relating to the regulation of human cells, tissues or cellular or tissue-based products (HCT/Ps).The FDA will hold a public hearing September 12 and 13, 2016, soliciting feedback from various sector stakeho ...


12.09.2016

The Alliance for Regenerative Medicine Releases Agenda for 2016 Cell & Gene Meeting on the Mesa

WASHINGTON, DC -- (Marketwired) -- 09/07/16 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader regenerative medicine sector, today released the agenda for its upcoming three-day Cell & Gene Meeting on the Mesa annual conference, October 5-7, 2016.Organized by ARM and the Sanford Consortium for Regenerative Medicine, the Cell & Gene Meeting on the Mesa is three-day conference featuring three distinct ...


07.09.2016

The Alliance for Regenerative Medicine Welcomes New Vice Chairman Matthew Patterson, President and CEO, Audentes Therapeutics

WASHINGTON, DC -- (Marketwired) -- 08/11/16 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cellular therapies and broader regenerative medicine sector, announced today that Matthew Patterson, president and CEO, Audentes Therapeutics, Inc., has been named vice chairman of ARM, effective immediately.Mr. Patterson currently serves as a member of ARM''s board of directors, providing insights regarding the strategic direct ...


11.08.2016

Alliance for Regenerative Medicine Releases Q2 2016 Data Report, Highlighting Sector Trends and Metrics

WASHINGTON, DC -- (Marketwired) -- 08/04/16 -- The Alliance for Regenerative Medicine (ARM) today announced the release of its quarterly data report, offering an in-depth look at cell therapy, gene therapy, tissue engineering and broader global regenerative medicine sector trends and metrics in the second quarter and first half of 2016.Using information provided by ARM''s data partner Informa, the quarterly data report details industry-specific statistics compiled from 700+ cell thera ...


04.08.2016

The Alliance for Regenerative Medicine Announces Presenting Companies at 2016 Cell & Gene Meeting on the Mesa

WASHINGTON, DC -- (Marketwired) -- 08/03/16 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader regenerative medicine sector, today announced the initial slate of companies selected to present at its upcoming three-day Cell & Gene Meeting on the Mesa annual conference, October 5-7, 2016.More than 60 prominent publicly traded and emerging private companies will present at this year''s Partnering ...


03.08.2016

The Alliance for Regenerative Medicine Announces 2016 Cell & Gene Meeting on the Mesa

WASHINGTON, DC -- (Marketwired) -- 07/14/16 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader regenerative medicine sector, announced it will hold its annual Cell & Gene Meeting on the Mesa this year on October 5-7, 2016 in La Jolla, California.This year''s event will attract more than 800 attendees, including senior executives from leading cell therapy, gene therapy and tissue engineering co ...


14.07.2016

The Alliance for Regenerative Medicine Welcomes New Chairman, Bob Preti, Ph.D., President of PCT and SVP of Caladrius Biosciences

WASHINGTON, DC -- (Marketwired) -- 06/27/16 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cellular therapies and broader regenerative medicine sector, announces that Robert A. Preti, Ph.D., president of PCT and Caladrius Biosciences'' senior vice president, manufacturing and technical operations, has been named chairman of ARM, effective immediately.Prior to this role, Dr. Preti served as ARM vice-chair from January ...


27.06.2016

The Alliance for Regenerative Medicine Announces Immuno-Oncology Clinical and Patient Education Roundtable

WASHINGTON, DC -- (Marketwired) -- 05/05/16 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cellular therapies and broader regenerative medicine sector, announced it will hold the Immuno-Oncology Clinical and Patient Education Roundtable May 24, the second event in its patient roundtable series.ARM''s patient roundtable series is intended to serve as an educational resource for the broader patient community and to help ...


05.05.2016

Alliance for Regenerative Medicine Releases Q1 2016 Data Report, Highlighting Sector Trends and Metrics

WASHINGTON, DC -- (Marketwired) -- 05/03/16 -- The Alliance for Regenerative Medicine (ARM) today announced the release of its quarterly data report, offering an in-depth look at cell therapy, gene therapy and broader global regenerative medicine sector trends and metrics in the first quarter of 2016.Using information provided by ARM''s data partner Informa, the quarterly data report details industry-specific statistics compiled from more than 685 leading cell therapy, gene therapy an ...


03.05.2016

The Alliance for Regenerative Medicine Establishes Patient Advocacy Coordinating Committee to Engage Key Patient-Related Stakeholders

WASHINGTON, DC -- (Marketwired) -- 04/20/16 -- The Alliance for Regenerative Medicine (ARM) today announces the formation of its Patient Advocacy Coordinating Committee to ensure alignment, engagement and education of patients and patient advocates relevant to gene therapies, cell therapies and other regenerative medicine products.The Patient Advocacy Coordinating Committee will coordinate ARM''s patient advocacy outreach and education agenda, as well as guide ARM''s efforts ...


20.04.2016

The Alliance for Regenerative Medicine and the International Society for Cellular Therapy Enter Into Memorandum of Understanding

WASHINGTON, DC and VANCOUVER, BC -- (Marketwired) -- 04/05/16 -- The Alliance for Regenerative Medicine (ARM), the international organization representing the gene and cellular therapies and the regenerative medicine sector, and the International Society for Cellular Therapy (ISCT), a global association driving the translation of scientific research to deliver innovative cellular therapies to patients, announced today they have entered into a memorandum of understanding (MOU).Signed by ISCT Pre ...


05.04.2016

The Alliance for Regenerative Medicine Released Agenda for Sixth Annual Advanced Therapies Summit

WASHINGTON, DC -- (Marketwired) -- 03/17/16 -- The Alliance for Regenerative Medicine (ARM) today released the complete agenda for its sixth annual Advanced Therapies Summit, taking place April 6, 2016 in Stockholm, Sweden. This one-day meeting is a gathering of the sector''s top executives, clinical researchers and policymakers across Europe and the United States to discuss how best to support the Advanced Therapies Medicinal Products (ATMP) sector.This multi-stakeholder, interactive ...


17.03.2016

BioStem Technologies Inc. (OTC: BSEM) Receives Prestigious 2016 Best of Oakland Park Award

OAKLAND PARK, FL -- (Marketwired) -- 03/16/16 -- BioStem Technologies Inc. (OTC PINK: BSEM) has been selected for the 2016 Best of Oakland Park Award by the Oakland Park Award Program.Each year, the Oakland Park Award Program identifies companies that we believe have achieved exceptional marketing success in their local community and business category. These are local companies that enhance the positive image of business through service to their customers and our community. These exceptional co ...


16.03.2016

The Alliance for Regenerative Medicine Releases Agenda for Fourth Annual Cell & Gene Therapy Investor Day

WASHINGTON, DC -- (Marketwired) -- 03/08/16 -- The Alliance for Regenerative Medicine (ARM) today released the complete agenda for its upcoming fourth annual Cell & Gene Therapy Investor Day, taking place March 22, 2016 in New York City. This event, co-hosted by Piper Jaffray, is expected to attract 350+ attendees, including credentialed investors, members of the media and leading sector executives.This event, featuring 30+ company presentations and five expert-led sessions, is the only inv ...


08.03.2016

The Alliance for Regenerative Medicine Commends U.S. Congressman Bill Foster and U.S. Senator Tammy Baldwin for Their Support of the Standards Coordinating Body for Regenerative Medicine

WASHINGTON, DC -- (Marketwired) -- 03/04/16 -- The Alliance for Regenerative Medicine (ARM) is pleased to announce U.S. Congressman Bill Foster (D-IL) has introduced the Advanced Standards in Regenerative Medicine Act, the House companion bill to S.2443 introduced by U.S. Senator Tammy Baldwin (D-WI) in January."We applaud Senator Baldwin''s and Congressman Foster''s leadership in promoting the need for industry-wide standards in this sector," said Michael Werner, ...


04.03.2016

The Alliance for Regenerative Medicine Announces Sixth Annual Advanced Therapies Summit

WASHINGTON, DC -- (Marketwired) -- 03/02/16 -- The Alliance for Regenerative Medicine (ARM) today announced its sixth annual Advanced Therapies Summit will take place April 6, 2016 in Stockholm, Sweden. This one-day meeting is a gathering of the sector''s top executives, clinical researchers and policymakers across Europe and the United States to discuss how best to support the Advanced Therapies Medicinal Products (ATMP) sector.This multi-stakeholder, interactive forum will feature h ...


02.03.2016

Alliance for Regenerative Medicine Releases 2015 Annual Data Report, Highlighting Sector Trends and Metrics

WASHINGTON, DC -- (Marketwired) -- 02/18/16 -- The Alliance for Regenerative Medicine (ARM) today announced the release of its annual data report, offering an in-depth look at sector trends and metrics in 2015.Using information provided by ARM''s data partner Informa, the annual data report details industry-specific statistics compiled from more than 670 leading gene therapy, cell therapy and other regenerative medicine companies worldwide, including total financings, partnering and d ...


18.02.2016

The Alliance for Regenerative Medicine Announces Fourth Annual Cell & Gene Therapy Investor Day & Initial Slate of Presenting Companies

WASHINGTON, DC -- (Marketwired) -- 02/02/16 -- The Alliance for Regenerative Medicine (ARM) today announced its annual Cell & Gene Therapy Investor Day will take place March 22, 2016 in New York City. The event is co-hosted by leading investment banking firm Piper Jaffray."Our sector is poised for a number of significant scientific and clinical breakthroughs in the very near term," said Edward Lanphier, ARM chairman and president and CEO of Sangamo BioSciences. "Cell, gene an ...


02.02.2016

Biostem Technologies, Inc. (OTC: BSEM) Announces the Appointment of Dr. Dave Woynarowski as Chief Medical Officer

OAKLAND PARK, FL -- (Marketwired) -- 02/01/16 -- Dr. Dave Woynarowski was appointed Chief Medical Officer of Biostem Technologies, Inc. (OTC PINK: BSEM) effective immediately. Dr. Woynarowski received his medical degree from Temple University, and served as chief resident in his Internal Medicine Training program. He went on to become part of the resident education system, and twice receiving the prestigious Residents Teaching Award from his students and residents. He holds a Master'' ...


01.02.2016

Biostem Technologies, Inc. (OTC: BSEM) Announces Commencement of International Operations in Guadalajara, Mexico

OAKLAND PARK, FL -- (Marketwired) -- 01/28/16 -- (OTC PINK: BSEM), Biostem Technologies, Inc. We are pleased to announce that Biostem Technologies, Inc. has entered into an agreement with Dr. Jesus Esparragoza Romano and his team in Guadalajara, Mexico to form the Mexican entity -- Bio ST Holdings, S. de R.L. de C.V. which is a wholly owned subsidiary of Biostem Technologies, Inc.Biostem Technologies, Inc. is also proudly announcing the addition of cardiologist, Dr. Jesus Esparragoza Romano, as ...


28.01.2016

The Alliance for Regenerative Medicine Announces First Event in Patient Roundtable Series

WASHINGTON, DC -- (Marketwired) -- 01/20/16 -- The Alliance for Regenerative Medicine (ARM), the international organization representing the gene therapy, cell therapy and tissue engineering sectors, announced the first event in its patient advocacy roundtable series, the Rare Disease Clinical and Patient Education Roundtable, to be held January 27, 2016 in Washington, D.C.ARM''s patient roundtable series is intended to serve as an educational resource for the broader patient communit ...


20.01.2016

The Alliance for Regenerative Medicine Announces 2016 Regen Med and Advanced Therapies State of the Industry Briefing

WASHINGTON, DC -- (Marketwired) -- 01/06/16 -- The Alliance for Regenerative Medicine (ARM), the international organization representing the gene therapy, cell therapy and tissue engineering sectors, announced its 2016 Regen Med & Advanced Therapies State of the Industry briefing will take place January 11, 2016 in San Francisco.The briefing will provide a comprehensive industry update detailing key sector trends and metrics, anticipated clinical data events, recent advances and the outlook ...


06.01.2016

The Alliance for Regenerative Medicine Submits Comments to the European Commissions Stakeholder Consultation Document on Good Manufacturing Practice for Advanced Therapy Medicinal Products (ATMP)

BRUSSELS, BELGIUM and WASHINGTON, DC -- (Marketwired) -- 11/12/15 -- ARM welcomes this initiative and supports the Commission in seeking targeted stakeholder input to develop Good Manufacturing Practice (GMP) requirements appropriately suited to the specific characteristics of Advanced Therapy Medicinal Products (ATMP).The Alliance for Regenerative Medicine (ARM), the international organization representing the gene therapy, cell therapy and tissue engineering sectors, announced today it has su ...


12.11.2015

Alliance for Regenerative Medicine Releases Q3 2015 Data Report, Highlighting Sector Trends and Metrics

WASHINGTON, DC -- (Marketwired) -- 11/04/15 -- The Alliance for Regenerative Medicine (ARM), the international organization representing the regenerative medicine and advanced therapies community, today announced the release of its quarterly data report, offering an in-depth look at sector trends and metrics July through September 2015.Using information provided by ARM''s data partner , the quarterly report details industry-specific statistics compiled from more than 580 leading thera ...


04.11.2015

The Alliance for Regenerative Medicine Names 32 Member Representatives as New Board of Directors

WASHINGTON, DC -- (Marketwired) -- 10/07/15 -- The Alliance for Regenerative Medicine (ARM), the international organization representing the gene therapy, cell therapy and tissue engineering sector, announced it has named its new board of directors, effective immediately.The board''s primary responsibilities are to set the overall vision and direction for the organization, in addition to approving the annual budget and voting on any necessary by-law amendments."Throughout this pr ...


07.10.2015

The Alliance for Regenerative Medicine Submits Comments to the European Medicines Agency''s Draft Guideline on Gene Therapy Medicinal Products

BRUSSELS, BELGIUM and WASHINGTON, DC -- (Marketwired) -- 09/01/15 -- The Alliance for Regenerative Medicine (ARM), the international organization representing the gene therapy, cell therapy and tissue engineering sectors, announced today it has submitted its comments in response to the European Medicines Agency''s (EMA) draft guidance entitled "Guideline on the Quality, Non-Clinical and Clinical Aspects of Gene Therapy," first published for comment on May 20, 2015."ARM ...


01.09.2015

The Alliance for Regenerative Medicine Announces Presenting Companies at 2015 Stem Cell Meeting on the Mesa

WASHINGTON, DC -- (Marketwired) -- 08/06/15 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the interests of the advanced therapies and regenerative medicine community, today announced the initial slate of companies selected to present at its upcoming Stem Cell Meeting on the Mesa (SCMOM) Partnering Forum.The meeting will feature presentations from more than 60 leading companies in the fields of cell therapy, gene and gene-modified cell ther ...


06.08.2015

StockNewsNow.com Publishes New SNNLive Video Interviews With Cesca Therapeutics, Inc.

LOS ANGELES, CA -- (Marketwired) -- 08/05/15 -- , The Official MicroCap News Source™, today published two SNNLive Video Interviews with Kenneth Harris, President, and Robin Stracey, Director and CEO of Cesca Therapeutics, Inc. (NASDAQ: KOOL), engaged in the research, development and commercialization of autologous cell-based therapeutics for use in regenerative medicine, according to the company''s website (see here: ). The video interview with Mr. Harris was recorded at the Marcum Mi ...


05.08.2015

CCRM Takes on Commercialization Role With Medicine by Design

TORONTO, ONTARIO -- (Marketwired) -- 07/30/15 -- Editors Note: There is a photo associated with this press release.The Centre for Commercialization of Regenerative Medicine (CCRM) is pleased to support a new medical research program at the University of Toronto, announced this week, by the Government of Canada. CCRM will be the commercialization partner for regenerative medicine technologies developed under "Medicine by Design," a $114 million federal investment that is part of the go ...


30.07.2015

Alliance for Regenerative Medicine Releases Q2 2015 Data Report, Highlighting Sector Trends and Metrics

WASHINGTON, DC -- (Marketwired) -- 07/29/15 -- The Alliance for Regenerative Medicine (ARM), the international organization representing the regenerative medicine and advanced therapies community, today announced the release of a new data report, offering an in-depth look at sector trends and metrics from the months April through June 2015.Using information provided by ARM''s data partner , the quarterly report details sector-specific statistics compiled from more than 580 leading com ...


29.07.2015

Avita Medical''s ReCell(R) Recognized as Innovative Treatment for Burn Victims

NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM -- (Marketwired) -- 07/20/15 -- Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY), a medical device company specializing in the treatment of wounds and skin defects, today said a branch of the U.S. Military says the U.S. Department of Defense ''wants to use'' the company''s ReCell® technology, which it described as offering a possible ''paradigm shift'' in skin injury treatment.The July/August 2015 issue ...


20.07.2015

Philip Vanek, GE Healthcare, Joins CCRM''s Board of Directors

TORONTO, ONTARIO -- (Marketwired) -- 07/16/15 -- Philip Vanek, General Manager, Cell Therapy Technologies, GE Healthcare, has joined the Centre for Commercialization of Regenerative Medicine''s (CCRM) Board of Directors."Phil Vanek is a very welcome addition to CCRM''s Board," says Greg Bonfiglio, CCRM Board Chair and Managing Partner of Proteus Venture Partners. "GE Healthcare has been supportive of CCRM since we launched four years ago and Phil''s ...


16.07.2015

The Alliance for Regenerative Medicine Announces 2015 Stem Cell Meeting on the Mesa

WASHINGTON, DC -- (Marketwired) -- 07/08/15 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the regenerative medicine and advanced therapies community, announced it will hold its annual Stem Cell Meeting on the Mesa. The conference is the sector''s premier forum, bringing together senior executives and top decision makers in the industry with the scientific community, with the shared goal of advancing and translating cutting-edge r ...


08.07.2015

US Equity Holdings Secures Funding to Launch Aelan Cell Technologies -- A Stem Cell R&D Technology Company Focused on Aging and Regenerative Medicine

SAN FRANCISCO, CA -- (Marketwired) -- 06/02/15 -- announced today that it has secured funding to launch , a biotech startup engaged in the research, discovery, development and commercialization of innovative biomedical technologies and diagnostic tools for the advancement of human health and longevity.US Equity Holdings Chairman and CEO Chester Aldridge co-founded Aelan Cell Technologies with Dr. Victoria Lunyak, Aelan''s chief executive officer and president."Victoria has a dis ...


02.06.2015

The Alliance for Regenerative Medicine Issues Position Statement Regarding Human Embryo Germline Genome Editing

WASHINGTON, DC -- (Marketwired) -- 06/02/15 -- The Alliance for Regenerative Medicine (ARM), the international organization representing the regenerative medicine and advanced therapies community, today released its position statement regarding human germline modification.ARM''s position is that it is neither appropriate nor acceptable to pursue this kind of research at this time, given the highly premature stage of germline modification technology and the many scientific and ethical ...


02.06.2015

The Alliance for Regenerative Medicine Announces Speakers and Award Recipients for Sixth Annual Dinner and Legislative Fly-In

WASHINGTON, DC -- (Marketwired) -- 05/27/15 -- The Alliance for Regenerative Medicine (ARM), the international organization representing the regenerative medicine and advanced therapies community, announced the speaker line up for its sixth Annual Dinner and Legislative Fly-In, being held June 9 and 10 in Washington, D.C. This is the sector''s main advocacy event in Washington, D.C. to call attention to key legislation, honor industry leaders and celebrate recent accomplishments.ARM&# ...


27.05.2015

The Alliance for Regenerative Medicine Welcomes Two New Staff Additions to Drive ARMs Expanding European Activities

WASHINGTON, DC -- (Marketwired) -- 05/12/15 -- The Alliance for Regenerative Medicine (ARM), the international organization representing the regenerative medicine and advanced therapies community, continues to expand its presence in Europe with the appointment of Annie Hubert as the new director of European public policy and Caroline Ruggieri as the new director of the organization''s European section."We are so pleased to welcome Annie and Caroline to our team," said Morrie ...


12.05.2015

Industry Collaborations Are Key CCRM Strategy to Drive Commercialization in Regenerative Medicine Field

TORONTO, ONTARIO -- (Marketwired) -- 05/06/15 -- In under four years, the Centre for Commercialization of Regenerative Medicine (CCRM) has established an industry consortium of 45 companies, from around the globe, including Big Pharma and Canadian startups, that cover the key sectors in regenerative medicine (RM). These include companies like Canadian success story STEMCELL Technologies, and multinational firms such as GE Healthcare, Pfizer, Amgen, Lonza and Thermo Fisher, that specialize in re ...


06.05.2015

TissueGen Expands Core Team and Advances Spinal Cord Injury Repair and Regenerative Medicine Applications in 2014

DALLAS, TX -- (Marketwired) -- 01/20/15 -- , developer of , a groundbreaking biodegradable fiber format for advanced drug delivery, closed out 2014 with the establishment of a senior scientist position to manage the company''s spinal cord injury (SCI) repair program. The growth of TissueGen''s core team -- which the company expects to continue to grow in 2015 by as much as 50% -- is a fitting end to a year marked by expansion and R&D in additional application markets and ...


20.01.2015

New Ontario Institute to Tackle Costly Diseases of Aging

TORONTO, ONTARIO -- (Marketwired) -- 11/25/14 -- Ontario is a leader in regenerative medicine research. To support advances in this field and to address the staggering costs of chronic and degenerative diseases affecting Ontario''s aging population, the Government of Ontario has awarded new funding to the (OSCI) and the (CCRM) to establish the Ontario Institute for Regenerative Medicine (OIRM) - a research, development and commercialization institute dedicated to the translation of ...


25.11.2014

The Alliance for Regenerative Medicine (ARM) and the Alliance for Advanced Therapies (AAT) Merge to Create One Unified Voice for Next Generation Therapies in Europe and the U.S.

WASHINGTON, DC -- (Marketwired) -- 10/16/14 -- The Alliance for Regenerative Medicine (ARM), along with its European sister organization, the Alliance for Advanced Therapies (AAT), today announced the leadership of both organizations has approved a Memorandum of Understanding to merge the membership of AAT into ARM. The result of this membership merger is the creation of one global organization operating on behalf of the advanced therapies and regenerative medicine sector (cell therapy, gene th ...


16.10.2014

Columbus Doctor Reveals Technological Advances in Regenerative Medicine

COLUMBUS, OH -- (Marketwired) -- 10/16/14 -- of the Ohio State University Department of Plastic Surgery has been researching regenerative medicine for nearly two decades. His research during this time has made significant contributions toward the development of medical 3D printing and bone tissue engineering. Dr. Dean recently authored a series of blog posts, shedding light on how the technological innovations of his lab have improved the ways in which surgeons approach ."When patients ne ...


16.10.2014

Avita Medical Secures US FDA Approval to Modify ReCell(R) Clinical Burns Trial

NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM -- (Marketwired) -- 09/16/14 --The US FDA has approved Avita''s request for expanded use of ReCell® and broadened eligibility criteria for study participantsThe broadened eligibility criteria are anticipated to resolve ongoing delays with recruitment, and simultaneously position ReCell for a wider commercial opportunityThe revised eligibility criteria allow for treatment of more extensive and severe (deeper) burn injuries, and include partic ...


16.09.2014

The Alliance for Regenerative Medicine Announces Fourth Annual State of the Industry Briefing

WASHINGTON, DC -- (Marketwired) -- 12/12/13 -- The Alliance for Regenerative Medicine (ARM), the international organization representing the interests of the regenerative medicine community, today announced that the fourth annual State of the Industry Briefing will take place on Monday, January 13, 2014 in San Francisco.During the Briefing, leading experts in the field will discuss key clinical data inflection points expected in 2014 as well as a retrospective look at the sector's major re ...


12.12.2013

Avita Medical: Update to Shareholders

NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM -- (Marketwired) -- 12/11/13 -- (ASX: AVH) (OTCQX: AVMXY)Regenerative medicine Company (ASX: AVH), (OTCQX: AVMXY) provides the following update to shareholders about a number of changes to the company.Avita Medical Managing Director and CEO Dr William Dolphin has agreed to step down as CEO and from the Board of Directors and will be replaced in an interim capacity by current Chief Operating Officer & Chief Financial Officer, Mr Timothy Rooney, u ...


11.12.2013

The Alliance for Regenerative Medicine Gains Bipartisan Support for GAO Assessment of Federal Regenerative Medicine Activities

WASHINGTON, DC -- (Marketwired) -- 11/12/13 -- The Alliance for Regenerative Medicine (ARM), the largest multi-stakeholder advocacy organization representing regenerative medicine, announced that a letter signed by six bipartisan Senators has been sent to the U.S. Government Accountability Office (GAO) requesting the agency to assess all current federal activities impacting the field of regenerative medicine. The full letter can be found at ."We are thrilled to have the support of this bip ...


12.11.2013

International Stem Cell and Regenerative Medicine Community Convenes in Banff, Alberta

OTTAWA, ONTARIO and TORONTO, ONTARIO -- (Marketwired) -- 10/21/13 -- Stem cell and regenerative medicine experts from around the world will physically and virtually come together in Banff, Alberta, when Canada's premier stem cell research event - the Till & McCulloch Meetings (T&MM) - takes place October 23-25, 2013."Canada and Europe chose the same dates to host their most significant regenerative medicine events and we're utilizing technology to bring the two conference ...


21.10.2013

Avita Medical Announces Positive Interim Clinical Study Results on Restoration of Pigment in Burn Scars at Clinical Cosmetic & Reconstructive Expo

NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM -- (Marketwired) -- 10/18/13 -- Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY)Regenerative medicine Company (ASX: AVH) (OTCQX: AVMXY) is pleased to report the presentation of results obtained with the use of ReCell® Spray-On Skin® at the recent Clinical Cosmetic & Reconstructive Expo held in London, England 11-12 October, 2013.Positive interim results on an investigator-led study on ReCell® for the restoration of pigment in hypopigmented burn scar ...


18.10.2013

The Alliance for Regenerative Medicine Issues Statement Regarding CIRM President Alan Trounson's Decision to Step Down

WASHINGTON, DC -- (Marketwired) -- 10/17/13 -- The Alliance for Regenerative Medicine (ARM), the largest multi-stakeholder advocacy organization representing regenerative medicine, issues the following statement about the announcement of Dr. Alan Trounson's decision to step down as President of the California Institute for Regenerative Medicine (CIRM)."We owe a huge debt of gratitude to Alan for his pivotal contributions to the field of regenerative medicine," said Morrie Ruffin, ...


17.10.2013

Comprehensive Portfolio Prepared by the Alliance for Regenerative Medicine Guides Companies Through Reimbursement Process

LA JOLLA, CA -- (Marketwired) -- 10/14/13 -- A comprehensive reimbursement guide for regenerative medicine was released today at the third annual Stem Cell Meeting on the Mesa Regen Med Partnering Forum. This guide was developed by the Alliance for Regenerative Medicine (ARM), an international organization representing the regenerative medicine community, and comprises a series of white papers designed to help regenerative medicine companies navigate the reimbursement process.As with all therap ...


14.10.2013

360ip and CCRM Join Forces to Source Best IP in Regenerative Medicine

SINGAPORE AND TORONTO, ONTARIO -- (Marketwired) -- 10/11/13 -- 360ip and the Canadian Centre for Commercialization of Regenerative Medicine (CCRM) are signing a collaboration agreement to work together in a variety of areas, including developing a fund to invest in best-in-class regenerative medicine (RM) technologies and companies in Asia, Europe and North America."360ip has expertise in identifying, commercializing and monetizing intellectual property (IP) worldwide with a particular f ...


11.10.2013



All members: 9 408
Register today: 0
Register yesterday: 2
Members online: 0
Guests online: 54


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.